GBM
GBM
GBM
ABSTRACT
GLIOBLASTOMA MULTIFORME
Hening Widjayanti* Soetedjo **
Background:.Glioblastoma (GBM) is the most common glioma (a type of cancer of the brain) where
the tumor is found most malignant brain that comes from glial cellsAnaplasticastrocytomasaffectmales
slightly more often than females. The symptoms of glioblastoma multiforme vary depending uponthe exactlocation and
sizeofthetumor.Anglioblastomamultiformeusuallydevelopsslowlyovertime,butmaydeveloprapidly.
CaseReport:Reportedcaseofaman,29 years old man, Javannesse, a housewife, right handed, married, came with chief
complaint chronic progressive headache, blurred vision, seizures, nausea and vomiting since 8 months before admission. On
contrast head CT scan appeared SOL in Frontal. A collection of signs and symptoms consistent leading to increased
Intracranial Pressure due to SOL Frontal Region.. From the physical examination found cerebellar signs The
hystopathologicalexaminationwasglioblastomamultiforme.Byanamnesis,physicalexamination,andimagingstudy,tend
to be a SOL in the frontal. The management of patients with symptomatic treatment and resection of the tumor.
HystopathologicexaminationresultssupportthediagnosisofGlioblastomaMultiforme
Conclusion
Reported case a patients with vestibular vertigo, chronic progressive cephalgia, and ataxia accompanied by nausea and
vomitingsince3months.Acollectionofsignsandsymptomsinpatientsconsistentwithincreasedintracranialpressuredue
to the mass in the cerebellum. Management of these patients are sympotamatic medication and tumor resection, with
hystopathologic examination. Hystopathologic examination results is Glioblastoma Multiforme During the postoperative
care,patient'sconditionisthesame,butbetter.
Keyword:GlioblastomaMUltiforme,diagnosis,prognosis,theraphy
INTRODUCTION
Glioblastoma is usually found in adults consists of a
heterogeneous mixture of poorly differentiated neoplastic
astrocytes which are located in the cerebral hemispheres
ANATOMY
ma
o
t
s
a
l
b
) is
Glio
M
B
G
(
rme
multifo
y brain
r
a
m
i
r
the p
ith the
w
s
r
o
an d
e
tum
c
n
e
d
i
t inc
ive.
s
highes
s
e
r
g
st ag
the mo
DEFINITION
HO
W
t
s
te
The la ation GBM
IV
fic
classi as Grade
fy
classi toma
y
astroc
Etiology
No definitive cause
Believed to be result of genetic
mutations that
result in uncontrollable growth of
specific types
of brain cells
Family hx accounts for <5% of
causes for
developing these tumors
No direct linkage between lifestyle
factors and
malignant gliomas (alcohol, smoking,
etc)
Demographics
-Overall
GBM Pathophysiology
Tumor infiltration often
extends into the adjacent
cortex or the basal
ganglia
- signs & symptoms with basal
ganglia pathology?
Tumors in the frontal cortex
can spread across the corpus
callosum
into the contralateral
hemisphere, creating the
appearance of a
symmetric lesion, called a
butterfly glioma.
Glial cell
in the
brain
provide
nutrients and
energy to
neurons
astrosit
oligodendrosi
t
mikroglia
ependim
Glioblastoma =
astrositoma grade IV.
The types og
glial cell
Clinical Manifestations
aries depending on the size and location of the tumo
The most common symptoms:
Headache (80%)
Seizure (30%)
Neurological focal deficit
(40- 60%)
Mental status changes (2040%)
Time of onset of symptom
onset and diagnosis is usually
<6 months
HISTOLOGY
The etiology
is unknown
GBM
Genetic pathways in
the development of
GBM
GBM De Novo
(primer)
In the group of
elderly
Overexpression of
Epidermal Growth
Factor Receptor
(EGFR) PTEN
mutations deletions
p16INK4A
GBM Sekunder
The younger
age group
Evolving from a benign
tumor malignant
transformation
TP53 gene mutations
and retinoblastoma
DIAGNOSIS
DIAGNOSTIC EXAMINATION
TREATHMENT
MANAGEMENT
Surgery maximum removal of tumor
tissue is recommended if the tumor can
be removed without causing the loss of
certain functions
Recommended Radiation performed 6 weeks
after surgery with multiple fractions
Admittedly radiation increases the life
expectancy of up to 12-18 months.
chemotherapy given during and after radiation
for 6-12 months. Active Agents: Nitrosurea,
Carmustine, lomustine. Alkilating agents:
procarbazine, temazolamide, and vincristine
KOMPLIKA
SI
PROGNOS
IS
PENCEGA
HAN
???
PROGNOSI
S
THANKS YOU
DAFTAR PUSTAKA
Ovedoff, David. 2002. Kapita Selekta Kedokteran Jilid 2.
Binarupa Aksara. Jakarta.
The Oncology Group. 2003. Cancer Management : A
Multidiciplinary Approach.
Oncology. News Interantional. New York.
Curr Top Med Chem. 2005. 5(12) : 1151-1170.
Combining Cytotoxic and Immune Mediated Gene Therapy to Traet Brain Tumors.
Neuro-oncol. 2005. 10. 1215/S1152851704000584.
Well-differentiated Neurocytoma :
What Is The Best Avialable Treatment?